RECURRENT LOW GRADE GLIOMA
Clinical trials for RECURRENT LOW GRADE GLIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT LOW GRADE GLIOMA trials appear
Sign up with your email to follow new studies for RECURRENT LOW GRADE GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can we stop these cancer drugs without the tumor coming back?
Disease control Recruiting nowThis study looks at whether patients with a certain type of slow-growing brain tumor (low-grade glioma with a BRAF V600 mutation) can safely stop or reduce their dose of two targeted drugs, dabrafenib and trametinib, after 12-24 months of treatment. About 96 participants will eit…
Matched conditions: RECURRENT LOW GRADE GLIOMA
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Laser zaps brain tumors in kids without open surgery
Disease control Recruiting nowThis study tests a laser treatment called LITT for children, teens, and young adults whose low-grade brain tumors have come back or grown after prior therapy. About 40 participants will receive the laser procedure to heat and destroy tumor tissue. The main goal is to see how many…
Matched conditions: RECURRENT LOW GRADE GLIOMA
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New hope for kids with brain tumors: targeted drug mirdametinib enters trial
Disease control Recruiting nowThis study tests a drug called mirdametinib in children, adolescents, and young adults with low-grade glioma, a type of brain tumor. The drug is designed to cross into the brain and block a protein that helps tumors grow. The trial has two phases: Phase 1 finds the safest dose, a…
Matched conditions: RECURRENT LOW GRADE GLIOMA
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New imaging agent could sharpen brain tumor detection
Diagnosis Recruiting nowThis study tests a radioactive tracer called FET that lights up brain tumor cells on a PET scan. Researchers want to see if FET can better detect whether a brain tumor has come back after treatment, and help tell high-grade from low-grade tumors. About 199 people with known or su…
Matched conditions: RECURRENT LOW GRADE GLIOMA
Sponsor: Thomas Hope • Aim: Diagnosis
Last updated Jun 27, 2026 12:03 UTC